Real-time enrollment status for this cns germinoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 3:19 AM UTC
| NCT Number | NCT06368817 |
| Recruiting Status | Recruiting |
| Condition | CNS Germinoma |
| Phase | PHASE2 |
| Target Enrollment | 240 participants |
| Active Locations | 96 sites in the US |
| Sponsor | Children's Oncology Group |
| Last Updated on CT.gov | July 16, 2026 (2 days ago) |
As of July 18, 2026: Clinical trial NCT06368817 is currently recruiting participants. This phase2 study for cns germinoma is actively seeking new participants at 96 locations across the United States. The study is sponsored by Children's Oncology Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06368817 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 96 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06368817 was last updated 2 days ago (July 16, 2026). HelloStudys verifies this status automatically.